The Science Behind
Fluorescence-Guided
Dentistry.
BioUView is built on a validated scientific foundation. Every clinical claim on this website is supported by peer-reviewed literature. This page summarizes the key studies — with full abstracts, key findings, and direct links to the source publications.
Peer-reviewed studies cited
Validated biofilm excitation wavelength
Validated calculus contrast wavelength
Sites with residual biofilm after white-light SRP
Autofluorescence-Based Detection Method for Dental Plaque Bacteria Using Multiple Wavelengths
Kim H, et al. — PMC8303189
Scientific Reports (Nature Portfolio)
Highest sensitivity wavelength for pathogenic biofilm
Porphyrin fluorescence emission color
Signal specific to mature pathogenic biofilm
Autofluorescence — no staining agent required
BioUView Relevance
This study is the direct scientific foundation for BioUView's 405nm Biofilm Mode. It validates that 405nm violet illumination produces the highest-sensitivity, most specific autofluorescence signal for the exact pathogenic bacteria responsible for periodontal disease and peri-implantitis — with no dye or staining required.
Fluorescence-Based Detection of Peri-Implant Disease: Subgingival Calculus and Biofilm Visualization
Research Group — PMC7996852
Frontiers in Dentistry / PMC
Sensitivity improvement over probing alone
Improved detection in pockets >5mm
365nm calculus contrast validated
Immediate visual feedback during debridement
BioUView Relevance
This study validates both wavelengths of BioUView's dual-UV system in the specific clinical context of peri-implant disease — the primary application for the platform. The 68% residual biofilm finding is particularly significant: it means that in over two-thirds of sites that appear clean under white light, pathogenic biofilm remains. BioUView's 405nm mode detects this invisible residual disease.
Biofilm Detection Using 405nm Fluorescence in Clinical Dentistry: Evidence and Applications
AdDent Clinical Research Team
AdDent Inc. — Clinical Evidence Ebook
Case acceptance when patients see biofilm
Porphyrin excitation validated across multiple bacteria
Patient education effect on treatment compliance
Intraoral fluorescence detection without dyes
BioUView Relevance
The AdDent ebook provides the clinical workflow validation that bridges laboratory science to chairside practice. The near-100% case acceptance finding is directly applicable to BioUView's patient education value proposition — when patients see their own biofilm glowing red on a chairside screen, treatment acceptance is no longer a conversation.
CDC Health Advisory: Dental Unit Waterline Contamination and Infection Control
CDC Division of Oral Health
Centers for Disease Control and Prevention — Health Advisory
CFU/mL — required waterline safety standard
Time for biofilm to form in untreated waterlines
Children infected in documented 2015–2016 outbreak
CDC Health Advisory issued
BioUView Relevance
This CDC Advisory establishes the regulatory urgency for BioUView's Dental Waterline application. The critical gap identified by the CDC — that chemical shock treatments cannot be visually verified inside the tubing — is precisely what BioUView's sub-millimeter videoscope with 405nm UV illumination addresses. BioUView is the only instrument that can inspect inside waterline tubing and confirm biofilm elimination.
Prevalence of Periodontitis in Adults in the United States: 2009–2014
Eke PI, Thornton-Evans GO, Wei L, Borgnakke WS, Dye BA, Genco RJ
Journal of Dental Research / CDC NHANES
US adults 30+ with periodontal disease
Severe periodontitis prevalence
Americans affected
Annual US dental expenditure
BioUView Relevance
This study establishes the scale of the market opportunity for BioUView. With 47.2% of US adults affected by the disease that BioUView is designed to detect and treat more effectively, the addressable patient population is not a niche — it is the majority of every general dentist's and periodontist's patient base.
The Critical Finding
"In 68% of sites that appeared clinically clean under white light after scaling and root planing, 405nm fluorescence imaging detected residual pathogenic biofilm."
— PMC7996852, Fluorescence-Based Detection of Peri-Implant Disease (2021)
This single finding defines the clinical case for BioUView. Two-thirds of treatment sites that a clinician believes are clean — based on the best available white-light assessment — still harbor the bacteria driving disease progression. Fluorescence-Guided Dentistry is not an enhancement to existing practice. It is the correction of a systematic diagnostic blind spot that has existed since the beginning of modern periodontics.
Technical Reference
The Dual-Wavelength Science
Violet · Biofilm Mode
Mechanism: Excites porphyrin metabolites produced by pathogenic bacteria including P. gingivalis, P. intermedia, and F. nucleatum.
Emission: Red-orange fluorescence in the 620–700nm range — visible as a glowing red signal against dark background tissue.
Clinical use: Detect residual pathogenic biofilm after instrumentation. Establish a definitive visual endpoint for treatment.
Evidence: PMC8303189 (highest sensitivity wavelength); AdDent 2024 (clinical validation); PMC7996852 (peri-implant application).
UV-A · Structure Mode
Mechanism: Excites natural fluorophores in healthy enamel and dentin (collagen, hydroxyapatite), producing blue-white fluorescence. Calculus does not fluoresce — appearing as a dark shadow.
Emission: Healthy tissue glows blue-white; calculus, caries, and defective margins appear dark — creating a high-contrast structural map.
Clinical use: Map calculus deposits before and after instrumentation. Detect caries and margin defects. Guide minimally invasive treatment.
Evidence: PMC7996852 (30–40% sensitivity improvement for subgingival calculus detection).